SCHEMBL8405201

SCHEMBL8405201

CCC=C(C(=O)CCC)C(=O)OCC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 3/20 0.47
GLO1 Q04760 1/20 0.47
ALDH1A1 P00352 4/20 0.42
CYP2D6 P10635 2/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
FAAH O00519 2/20 0.41
CES2 O00748 1/20 0.41
CES1 P23141 1/20 0.41
MEN1 O00255 4/20 0.41
KMT2A Q03164 4/20 0.41
MAPT P10636 5/20 0.38
LMNA P02545 4/20 0.38
CYP1A2 P05177 2/20 0.38
CYP2C19 P33261 2/20 0.38
MAPK1 P28482 2/20 0.38
CYP2C9 P11712 1/20 0.38
S1PR4 O95977 1/20 0.38
S1PR1 P21453 1/20 0.38
DHODH Q02127 2/20 0.37
GAA P10253 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11725432 1.00 NPSR1 (0.47) NPSR1GLO1ALDH1A1CYP2D6SMN1; SMN2
SCHEMBL1939600 0.83 NPSR1 (0.58) NPSR1GLO1ALDH1A1CYP2D6SMN1; SMN2
SCHEMBL13269641 0.83 NPSR1 (0.58) NPSR1GLO1ALDH1A1CYP2D6SMN1; SMN2
SCHEMBL7100668 0.81 NPSR1 (0.47) NPSR1GLO1ALDH1A1CYP2D6SMN1; SMN2
SCHEMBL7100670 0.81 NPSR1 (0.47) NPSR1GLO1ALDH1A1CYP2D6SMN1; SMN2
SCHEMBL13990779 0.79 NPSR1 (0.71) NPSR1GLO1ALDH1A1CYP2D6SMN1; SMN2
SCHEMBL4920432 0.79 NPSR1 (0.71) NPSR1GLO1ALDH1A1CYP2D6SMN1; SMN2
SCHEMBL11654386 0.79 NPSR1 (0.46) NPSR1GLO1ALDH1A1CYP2D6SMN1; SMN2
SCHEMBL7172751 0.79 NPSR1 (0.46) NPSR1GLO1ALDH1A1CYP2D6SMN1; SMN2
SCHEMBL11654385 0.79 NPSR1 (0.46) NPSR1GLO1ALDH1A1CYP2D6SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5952504-A REACTING A SULFONATED, HALOGENATED OR PHOSPHONATED 1,7-NAPHTHYRIDINE COMPOUNDS WITH AN AROMATIC AMINE DERIVATIVE; ANTIULCER AGENT YUNGJIN PHARMACEUTICAL COMPANY, LTD. (KR) 1999-09-14 US disclosed
EP-0843677-A1 4-AMINO-3-ACYLNAPHTHYRIDINE DERIVATIVES YUNGJIN PHARMACEUTICAL CO., LTD. (KR) 1998-05-27 EP disclosed
WO-1997003074-A1 4-AMINO-3-ACYLNAPHTHYRIDINE DERIVATIVES YUNGJIN PHARMACEUTICAL CO., LTD. (KR) 1997-01-30 WO disclosed
US-5432182-A Inhibitors of gastric acid secretion SMITHKLINE BEECHAM INTERCREDIT B.V. (NL) 1995-07-11 US disclosed
EP-0416749-B1 Substituted 4-aminoquinolines SMITHKLINE BEECHAM INTERCREDIT (NL) 1994-08-17 EP disclosed
EP-0342775-B1 4-AMINO-3-ACYLQUINOLINE DERIVATIVES AND THEIR USE AS INHIBITORS OF GASTRIC SECRETION SMITHKLINE BEECHAM INTERCREDIT B.V. (NL) 1993-09-15 EP disclosed
EP-0330485-B1 4-AMINO-3-ACYL QUINOLINE DERIVATIVES AND THEIR USE AS INHIBITORS OF GASTRIC ACID SECRETION SmithKline Beecham Intercredit B.V. (NL) 1993-05-26 EP disclosed
US-5143920-A Antiulcer, antisecretory SMITHKLINE BECKMAN INTERCREDIT B.V. (NL) 1992-09-01 US disclosed
US-5089498-A Gastrointestinal disorders SMITHKLINE BECKMAN INTERCREDIT B.V. (NL) 1992-02-18 US disclosed
US-5089504-A SUBSTITUTED 4-AMINOQUINOLINE DERIVATIVES AS GASTRIC ACID SECRETION INHIBITORS SMITHKLINE BECKMAN INTERCREDIT B.V. (NL) 1992-02-18 US disclosed
EP-0342775-A1 4-Amino-3-acylquinoline derivatives and their use as inhibitors of gastric secretion SMITHKLINE BEECHAM INTERCREDIT B.V. (NL) 1989-11-23 EP disclosed
EP-0339768-A1 4-Amino-3-acylquinoline derivatives, and their use as inhibitors of gastric secretion SMITHKLINE BECKMAN INTERCREDIT B.V. (NL) 1989-11-02 EP disclosed
WO-1989008104-A1 4-AMINO-3-ACYLQUINOLINE DERIVATIVES AND THEIR USE AS INHIBITORS OF GASTRIC SECRETION SMITHKLINE BECKMAN INTERCREDIT B.V. (NL) 1989-09-08 WO disclosed
WO-1989008105-A1 4-AMINO-3-ACYLQUINOLINE DERIVATIVES AND THEIR USE AS INHIBITORS OF GASTRIC SECRETION SMITHKLINE BECKMAN INTERCREDIT B.V. (NL) 1989-09-08 WO disclosed
EP-0330485-A1 4-Amino-3-acyl quinoline derivatives and their use as inhibitors of gastric acid secretion SmithKline Beecham Intercredit B.V. (NL) 1989-08-30 EP disclosed
US-4806549-A INHIBITOR OF GASTRIC ACID SECRETION SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1989-02-21 US disclosed
US-4806550-A 4-Amino-3-carbonyl substituted quinolines as inhibitors of gastric acid secretion SMITHKLINE & FRENCH LABORATORIES LIMITED (GB) 1989-02-21 US disclosed
WO-1988001621-A1 4-AMINOQUINOLINE DERIVATIVES AND THEIR USE AS MEDICAMENTS SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1988-03-10 WO disclosed
EP-0259174-A1 Derivatives of 4-aminoquinoline and their use as medicaments SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1988-03-09 EP disclosed
US-4025537-A Preparation of 3-carboalkoxy or 3-alkanoyl furans KRETCHMER RICHARD ALLAN 1977-05-24 US disclosed